No Data
No Data
Innovative Medical Management (002173.SZ): plans to invest in Hangzhou Quanzhen Medical Technology Co., Ltd.
On August 28th, Genlot announced that the company has signed a strategic capital increase agreement with Hangzhou Quanzhen Medical Technology Co., Ltd. (referred to as "Quanzhen Medical") and its existing shareholders. According to the agreement, the company will invest 27.94 million yuan of its own funds in Quanzhen Medical. After this investment is completed, the company will hold a 20.5532% equity stake in Quanzhen Medical. The company's strategic investment in Quanzhen Medical will help better integrate medical resources, address the company's funding needs, and promote the application of AI technology in the medical field.
Innovative Medical Management: Half-year report for the year 2024.
Innovative Medical Management: Summary of Half-Year Report in 2024.
Innovative medical management (002173.SZ) saw a net loss of 16.0296 million yuan in the first half of the year.
In the first half of 2024, Innovative Medical Management (002173.SZ) announced a revenue of 0.408 billion yuan, a year-on-year increase of 0.67%; a net loss of -16.0296 million yuan attributed to shareholders of the listed company, with an expanded losses year-on-year; the net profit deducted from non-recurring gains and losses attributed to shareholders of the listed company was -16.6072 million yuan; basic earnings per share was -0.040 yuan.
Innovative medical management (002173.SZ): Agreed to publicly transfer the entire equity of Shuanghua Hospital through Hua Hospital.
On August 1, Gelonghui reported that Innovative Medical Management (002173.SZ) announced that the board of directors of the company's sixth session held the fifth interim meeting of 2024 on August 1, 2024, and approved the Proposal on Agreeing to Publicly List and Transfer 100% Equity of Jianhua Hospital to Shuanghua Hospital. In order to improve asset management capability and operation quality, Jianhua Hospital Co., Ltd. (hereinafter referred to as "Jianhua Hospital") timely cut loss-making business units, and revitalized existing assets. It plans to publicly list and transfer 100% equity of Harbin Shuanghua Hospital Co., Ltd. (hereinafter referred to as "Shuanghua Hospital") on the Heilongjiang United Property Rights Exchange.
Innovative Medical Management: 2024 Interim Performance Forecast
No Data